XML 226 R22.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Income taxes
3 Months Ended 12 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Income Taxes    
Income taxes

Note 15 — Income Taxes

The Company has determined that a discrete year-to-date method of reporting would provide more reliable results for the quarters ended March 31, 2023, and March 31, 2024, due the difficulty in projecting future results.

The Company’s provision for income taxes was a $31 tax expense for the three months ended March 31, 2024, and a $15 tax benefit for the three months ended March 31, 2023. The Company maintains a valuation allowance on its deferred tax assets and intends to do so until there is sufficient evidence to support the reversal of all or some portion of this allowance.

For the three-month periods ended March 31, 2024, and 2023, the Company’s effective income tax rates were as follows:

    

2024

    

2023

 

Three months ended March 31,

(0.78)

%  

(7.97)

%

The effective tax rates for the three-months periods ended March 31, 2024, and 2023, respectively, was below the U.S. statutory tax rate of 21% primarily due to losses generated by the Company and the Company’s valuation allowance.

During the first quarter ended March 31, 2024, the Company determined that it experienced an ownership change as defined under Internal Revenue Code Section 382. The result of the ownership change is subjecting tax attributes to an annual limitation which includes the utilization of the Company’s net operating losses. The Company will continue to monitor ownership changes throughout future periods.

Note 16 — Income taxes

The components of the provision for income taxes for the years ended December 31, 2023, and 2022 were as follows:

    

2023

    

2022

Current:

Federal

$

272

$

State

 

7

 

5

Total current

 

279

 

5

Deferred:

 

 

  

Federal

 

(71)

 

1,096

State

 

 

104

Total deferred

 

(71)

 

1,200

Total income tax provision

$

208

$

1,205

    

2023

    

2022

Deferred Tax Assets:

Impairment

$

1,134

$

1,147

Accruals

 

107

 

108

Reserves

 

52

 

75

Interest carryforward

 

31

 

31

Net operating losses

 

3,849

 

2,387

Other

 

60

 

40

Financial instruments

1,392

Start-up costs

982

UNICAP 263A

 

175

 

395

Valuation allowance

 

(7,011)

 

(3,583)

Total deferred tax assets

$

771

 

600

Deferred Tax Liabilities:

Prepaid Expense

$

(162)

 

(24)

Other

 

(30)

 

(157)

Depreciation

 

(597)

 

(509)

Total deferred tax liabilities

 

(789)

 

(690)

Deferred tax (liabilities) assets, net

$

(18)

$

(90)

The total provision for income taxes for the years ended December 31, 2023, and 2022 varies from the federal statutory rate as a result of the following:

    

2023

    

2022

 

Loss before income tax expense

$

(22,060)

$

(12,085)

Statutory tax rate

 

21

%

 

21

%

Income tax (benefit) expense at federal statutory rate

 

(4,633)

 

(2,538)

Increase (decrease) resulting from:

 

 

  

Permanent differences

 

2,300

 

494

State income tax, net of federal benefit

 

(177)

 

(343)

Valuation allowance

 

3,428

 

3,583

Other, net

 

(710)

 

9

Income tax expense

 

208

 

1,205

Current income tax expense

 

279

 

5

Deferred income tax (benefit)

 

(71)

 

1,200

Total

$

208

$

1,205

Deferred income taxes reflect the impact of temporary differences between the amount of assets and liabilities recognized for financial reporting purposes and such amounts recognized for tax purposes. As a result of the Company’s evaluation of both the positive and negative evidence, the Company determined it does not believe it is more likely than not that its deferred tax assets will be utilized in the foreseeable future and has recorded a valuation allowance. For the year ended December 31, 2023, the Company

recognized income tax expense because of a true-up on the federal tax payable and interest on late payment of the federal tax payable. For the year ended December 31, 2022, the Company recognized income tax expense because of a change in valuation allowance.

Changes in the valuation allowance are as follows:

    

2023

    

2022

Balance, beginning of the year

$

3,583

$

Additions to valuation allowance

3,428

 

3,583

Balance, end of the year

7,011

 

3,583

The Company intends to continue maintaining a valuation allowance on its deferred tax assets until there is sufficient evidence to support reversal of all or some portion of these allowances.

The Company reported U.S. net operating loss carryforwards of $16,771 and state net operating loss carryforward of $22,416. For state income tax purposes, the Company has $20,218 of net operating losses which are subject to expiration. The carryforward life for the net operating losses is dependent on the rules for each jurisdiction and therefore the losses are subject to expiration with the earliest year being 2033 and the latest year being 2044. The U.S. net operating loss carryforwards of $16,771 of federal and $2,198 of state NOLs will not expire. In addition, the Company also had U.S. interest limitation carryforwards of $133 with an indefinite expiration date.

A reconciliation of unrecognized tax benefits is as follows:

    

2023

    

2022

Balance, beginning of the year

$

$

Additions

 

 

Balance, end of the year

 

 

The Company recognizes interest and penalties related to unrecognized tax benefits within the provision for income taxes in the consolidated statement of operation and as of December 31, 2023, and 2022, the Company did not accrue interest and penalties. The Company does not expect its unrecognized tax benefits to change significantly in the next twelve months. We file income tax returns in the U.S. as well as in various states and the Company notes that the earliest year open to examination is 2020. The Company is not currently under examination by any major tax jurisdiction.